tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GlaxoSmithKline Downgraded to Sell Amid Blenrep Sales Decline and Earnings Adjustments
RatingsGlaxoSmithKline Downgraded to Sell Amid Blenrep Sales Decline and Earnings Adjustments
2d ago
GSK
GSK price target lowered to 1,290 GBp from 1,355 GBp at Morgan Stanley
PremiumThe Fly
GSK price target lowered to 1,290 GBp from 1,355 GBp at Morgan Stanley
2d ago
GSK
GSK’s Long-term Study on CAB LA for HIV Prevention: Key Insights for Investors
PremiumCompany Announcements
GSK’s Long-term Study on CAB LA for HIV Prevention: Key Insights for Investors
2d ago
GSK
GSK’s New COPD Drug Study: What Investors Need to Know
PremiumCompany Announcements
GSK’s New COPD Drug Study: What Investors Need to Know
2d ago
GSK
GSK’s Linerixibat Study: A Potential Game-Changer for PBC Treatment
PremiumCompany Announcements
GSK’s Linerixibat Study: A Potential Game-Changer for PBC Treatment
2d ago
GSK
GSK’s Clinical Study on Depemokimab: A Potential Game-Changer in EGPA Treatment?
PremiumCompany AnnouncementsGSK’s Clinical Study on Depemokimab: A Potential Game-Changer in EGPA Treatment?
2d ago
GSK
GSK’s Bepirovirsen Study: A Potential Breakthrough for HIV and HBV Co-Infection
Premium
Company Announcements
GSK’s Bepirovirsen Study: A Potential Breakthrough for HIV and HBV Co-Infection
2d ago
GSK
GSK Executives Acquire ADSs Following Dividend Reinvestment
Premium
Company Announcements
GSK Executives Acquire ADSs Following Dividend Reinvestment
2d ago
GSK Faces FDA Advisory Committee Setback on Blenrep for Multiple Myeloma
PremiumCompany Announcements
GSK Faces FDA Advisory Committee Setback on Blenrep for Multiple Myeloma
3d ago
GSK Expands Share Buyback Program with Recent Purchase
PremiumCompany Announcements
GSK Expands Share Buyback Program with Recent Purchase
3d ago
GSK provides update on US FDA advisory committee review of Blenrep
PremiumThe Fly
GSK provides update on US FDA advisory committee review of Blenrep
3d ago
GSK
GSK and Iteos Therapeutics’ Promising Phase 3 Study on NSCLC Treatment
PremiumCompany Announcements
GSK and Iteos Therapeutics’ Promising Phase 3 Study on NSCLC Treatment
3d ago
GSK
ITOS
GSK’s New Phase 3 Study on Dostarlimab: A Potential Game Changer for Colon Cancer Treatment?
PremiumCompany AnnouncementsGSK’s New Phase 3 Study on Dostarlimab: A Potential Game Changer for Colon Cancer Treatment?
3d ago
GSK
GSK’s New HIV Treatment Study: A Potential Game-Changer for Investors
Premium
Company Announcements
GSK’s New HIV Treatment Study: A Potential Game-Changer for Investors
3d ago
GSK
GSK announces FDA approval of prefilled syringe presentation of Shingrix
Premium
The Fly
GSK announces FDA approval of prefilled syringe presentation of Shingrix
4d ago
GSK
GSK announces US FDA approved prefilled syringe presentation of SHINGRIX
PremiumThe Fly
GSK announces US FDA approved prefilled syringe presentation of SHINGRIX
4d ago
GSK
GSK’s Shingrix Vaccine Gains FDA Approval for Prefilled Syringe
PremiumCompany Announcements
GSK’s Shingrix Vaccine Gains FDA Approval for Prefilled Syringe
4d ago
GSK Continues Share Buyback with Recent Purchase
PremiumCompany Announcements
GSK Continues Share Buyback with Recent Purchase
4d ago
Trump says drug tariffs probable by August 1, semis coming soon, Bloomberg says
PremiumThe Fly
Trump says drug tariffs probable by August 1, semis coming soon, Bloomberg says
5d ago
MU
AMD
Sell Rating on GlaxoSmithKline Due to Concerns Over Blenrep’s Ocular Toxicity and Limited US Trial Applicability
PremiumRatingsSell Rating on GlaxoSmithKline Due to Concerns Over Blenrep’s Ocular Toxicity and Limited US Trial Applicability
5d ago
GSK
GSK Enhances Shareholder Value Through Strategic Buyback
Premium
Company Announcements
GSK Enhances Shareholder Value Through Strategic Buyback
5d ago
GSK and iTeos Therapeutics Advance Phase 3 NSCLC Study with Belrestotug and Dostarlimab
Premium
Company Announcements
GSK and iTeos Therapeutics Advance Phase 3 NSCLC Study with Belrestotug and Dostarlimab
5d ago
GSK
ITOS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >